Clarithromycin in treatment of early Lyme disease

Topics with information and discussion about published studies related to Lyme disease and other tick-borne diseases.
Post Reply
Martian
Posts: 1944
Joined: Thu 26 Jul 2007 18:29
Location: Friesland, the Netherlands

Clarithromycin in treatment of early Lyme disease

Post by Martian » Mon 3 Sep 2007 21:40

Free full text: http://aac.asm.org/cgi/reprint/40/2/468.pdf

Quote from the full text:
Unlike azithromycin, which is rapidly cleared from the extracellular compartments, and beta-lactams, which do not effectively enter the intracellular compartment, clarithromycin has the ability to achieve and maintain bacteriocidal levels both intracellularly and extracellularly. Thus, it may act upon spirochetes in either compartment.
Antimicrob Agents Chemother. 1996 Feb;40(2):468-9.

Clarithromycin in treatment of early Lyme disease: a pilot study.

Dattwyler RJ, Grunwaldt E, Luft BJ.

Lyme Disease Center, State University of New York at Stony Brook 11794-8161, USA.

Forty-one patients with erythema migrans were enrolled in an open-labelled pilot study of oral clarithromycin, 500 mg twice daily for 21 days, for the treatment of early Lyme disease. Immediately posttherapy, pretreatment signs and symptoms resolved among 91% of the 33 evaluable patients. At 6 months, all 28 of the evaluable patients were well. Clarithromycin shows promise as an effective agent for the treatment of early Lyme disease and warrants further study.

PMID: 8834900 [PubMed - indexed for MEDLINE]

Post Reply